Banner - NPPA Connect
Opinion|Videos|January 2, 2025

Utilizing Safety Data When Prescribing Ruxolitinib Cream for Atopic Dermatitis

The panelist discusses how safety data from clinical trials and real-world evidence should guide physicians in prescribing ruxolitinib cream, including patient monitoring protocols and managing potential adverse effects in atopic dermatitis treatment.